🎉 M&A multiples are live!
Check it out!
| Company | Headquarters | Sector | Stock Price | Enterprise Value | EV/Revenue | EV/EBITDA |
|---|---|---|---|---|---|---|
| AstraZeneca | United Kingdom of Great Britain and Northern Ireland | Biopharmaceuticals, Drug Development & Therapeutics | £138 | $307B | 5.3x | 15.3x |
| GSK | United Kingdom of Great Britain and Northern Ireland | Biopharmaceuticals, Drug Development & Therapeutics, Vaccines & Immunotherapies | £18 | $116B | 2.7x | 8.0x |
| Haleon | United Kingdom of Great Britain and Northern Ireland | Health & Beauty, Drug Development & Therapeutics | £4 | $53.7B | 3.7x | 14.6x |
| Hikma Pharmaceuticals | United Kingdom of Great Britain and Northern Ireland | Biopharmaceuticals, Drug Development & Therapeutics | £16 | $5.9B | 1.8x | 7.1x |
| Genus | United Kingdom of Great Britain and Northern Ireland | Agriculture, Genomics & Personalized Medicine, Bioindustrials | £26 | $2.6B | 2.8x | 15.6x |
| Oxford Nanopore Techs | United Kingdom of Great Britain and Northern Ireland | Pharma Diagnostics & Analytics, Medical Devices | £1 | $1.2B | 4.3x | -10.1x |
| HUTCHMED | United Kingdom of Great Britain and Northern Ireland | Biopharmaceuticals, Drug Development & Therapeutics | £2 | $1.2B | 2.1x | -233.0x |
| Oxford BioMedica | United Kingdom of Great Britain and Northern Ireland | Contract Research & Manufacturing, Drug Development & Therapeutics | £6 | $1.0B | 4.9x | -3858.0x |
| Allergy Therapuetics | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics, Vaccines & Immunotherapies | £0 | $883M | 10.4x | -44.0x |
| Avacta Group | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics, Pharma Diagnostics & Analytics | £1 | $468M | 237.2x | -14.9x |
| International Biotechnology Trust | United Kingdom of Great Britain and Northern Ireland | Private Equity, Asset Management | £9 | $429M | N/A | N/A |
| Faron Pharmaceuticals | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics, Vaccines & Immunotherapies | £2 | $296M | 5513701.7x | -11.1x |
| Animalcare Group | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics | £2 | $242M | 2.1x | 10.6x |
| Shield Therapeutics | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics | £0 | $173M | 3.3x | -18.6x |
| Scancell | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics, Vaccines & Immunotherapies | £0 | $132M | 41.6x | -7.1x |
| Bioventix | United Kingdom of Great Britain and Northern Ireland | Pharma Diagnostics & Analytics | £19 | $121M | 7.1x | 9.3x |
| 4basebio | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics, Genomics & Personalized Medicine | £7 | $120M | 52.5x | -5.6x |
| PureTech Health | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics, Biopharmaceuticals | £1 | $88.9M | 18.6x | -0.6x |
| Eco Animal Health Group | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics | £1 | $69.0M | 0.6x | 6.9x |
| Provexis | United Kingdom of Great Britain and Northern Ireland | Nutraceuticals & Cosmeceuticals | £0 | $16.5M | N/A | N/A |
| Eden Research | United Kingdom of Great Britain and Northern Ireland | Agriculture, Bioindustrials | £0 | $13.5M | 2.1x | -5.2x |
| GenIP | United Kingdom of Great Britain and Northern Ireland | Vertical AI Applications, Pharma Diagnostics & Analytics | £0 | $3.2M | N/A | N/A |
| Futura Medical | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics | £0 | -$0.1M | -0.0x | -0.1x |
Valuation multiples as of last 12 months (LTM). Stock prices as of December 4, 2025. Financial data powered by Morningstar and FactSet.
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.